Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma

Copyright © 2022 Elsevier Inc. All rights reserved..

PURPOSE: To assess the within-trial cost-effectiveness of a behavioral intervention to improve glaucoma medication adherence.

DESIGN: Prospective cost-effectiveness analysis of randomized, controlled trial data.

METHODS: The study setting was a Veterans Affairs (VA) eye clinic. The patient population comprised veterans with medically treated glaucoma and self-reported poor adherence. Participants were randomized to a personalized educational session with a reminder bottle to promote medication adherence or to a control session on general eye health. Costs were assessed from the perspective of the VA payor at 6 months using the VA Managerial Cost Accounting System. Probabilistic sensitivity analyses were conducted using bootstrapped samples. The main outcome measures were the proportion of participants attaining ≥80% adherence as measured by electronic monitor, total intervention and medical resource costs, and incremental cost-effectiveness ratios comparing intervention to control at 6 months.

RESULTS: Of 200 randomized participants, 95 of 100 assigned to the intervention and 97 of 100 assigned to the control had adherence outcomes at 6 months, and the proportion of adherent patients was higher in the intervention group compared to control (0.78 vs 0.40, P < .0001). All participants had costs at 6 months. The total cost at 6 months was $1,149,600 in the intervention group (n = 100) compared to $1,298,700 in the control group (n = 100). Thus, in a hypothetical cohort of 100 patients, the intervention was associated with cost savings (-$149,100) and resulted in 38 additional patients achieving medication adherence.

CONCLUSIONS: An adherence-enhancing behavioral intervention was effective and cost saving at 6 months.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:244

Enthalten in:

American journal of ophthalmology - 244(2022) vom: 25. Dez., Seite 216-227

Sprache:

Englisch

Beteiligte Personen:

Williams, Andrew M [VerfasserIn]
Theophanous, Christos [VerfasserIn]
Muir, Kelly W [VerfasserIn]
Rosdahl, Jullia A [VerfasserIn]
Woolson, Sandra [VerfasserIn]
Olsen, Maren [VerfasserIn]
Bosworth, Hayden B [VerfasserIn]
Hung, Anna [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

Anmerkungen:

Date Completed 30.11.2022

Date Revised 02.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ajo.2022.08.011

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345205332